The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice

Journal of Experimental Medicine

Volumn 183, Issue 6, 1996, Pages 2645-2656

  Baker, Matthew B ^a   Altman, Norman H ^a   Podack, Eckhard R ^a   Levy, Robert B ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CACHEXIA; CYTOTOXIC T LYMPHOCYTE; GRAFT VERSUS HOST REACTION; IMMUNOPATHOGENESIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD95; BONE MARROW TRANSPLANTATION; CYTOTOXICITY, IMMUNOLOGIC; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; IMMUNOPHENOTYPING; LYMPHOCYTE TRANSFUSION; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, MUTANT STRAINS; PORE FORMING CYTOTOXIC PROTEINS; SKIN; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029953810     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.6.2645     Document Type: Article

References (38)

1. Martin, P.J., J.A. Hansen, R. Storb, and E.D. Thomas. 1987. Human marrow transplantation: an immunological perspective. Adv. Immunol. 40:379-438.
2. Chao, N.J. 1994. Graft-Versus-Host Disease: Past, Present and Future. R.G. Landes Company, Austin, TX. 150 pp.
3. Ferrara, J.L.M., and H.J. Deeg. 1991. Graft-versus-host disease. New Engl. J. Med. 324:667-674.
4. Lerner, K.G., G.F. Kao, R. Storb, C.D. Buckner, R.A. Clift, and E.D. Thomas. 1974. Histopathology of graft-vs-host reaction (GVHR) in human recipients of marrow from HLA-matched sibling donors. Transplant. Proc. 6:367-371.
5. Korngold, R., and J. Sprent. 1978. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. J. Exp. Med. 148:1687-1698.
6. Prentice, H.G., G. Janossy, D. Skeggs, H.A. Blacklock, K.F. Bradstock, G. Goldstein, and A.V. Hoffbrand. 1982. Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone marrow transplantation for acute leukemia. Lancet. ii:700-703.
7. Elkins, W.L. 1976. Correlation of graft-versus-host mortality and positive CML assay in the mouse. Transplant. Proc. 8: 343-347.
8. Hamilton, B.L. 1984. Absence of correlation between cytolytic T lymphocytes and lethal murine graft-versus-host disease in response to minor histocompatibility antigens. Transplantation 38:357-360.
9. Thiele, D.L., M.R. Charley, J.A Calomeni, and P.E. Lipsky. 1987. Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells. J. Immunol. 138:51-57.
10. Thiele, D.L., S.E. Bryde, and P.E. Lipsky. 1988. Lethal graft-vs-host disease induced by a class II MHC antigen only disparity is not mediated by cytotoxic T cells. J. Immunol. 141: 3377-3382.
11. Roosnek, E., S. Hogendijk, S. Zawadynsky, D. Speiser, J.M. Tiercy, C. Helg, U. Chapuis, A. Gratwohl, J. Gmür, R. Seger, and M. Jeannet. 1993. The frequency of pretransplant donor cytotoxic T cell precursors with anti-host specificity predicts survival of patients transplanted with bone marrow from donors other than HLA-identical siblings. Transplantation. 56:691-696.
12. Fussell, S.T., M. Donnellan, M.A. Cooley, and C. Farrell. 1994. Cytotoxic T lymphocyte precursor frequency does not correlate with either the incidence or severity of graft-versus-host disease after matched unrelated donor bone marrow transplantation. Transplantation. 57:673-676.
13. Korngold, R., and P.J. Wettstein. 1990. Immunodominance in the graft-vs-host disease T cell response to minor histocompatibility antigens. J. Immunol. 145:4079-4088.
14. Podack, E.R., H. Hengartner, and M.G. Lichtenheld. 1991. A central role of perforin in cytolysis? Annu. Rev. Immunol. 9: 129-157.
15. Kägi, D., F. Vignaux, B. Ledermann, K. Bürki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science (Wash. DC.) 265:528-530.
16. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature (Lond.). 370:650-652.
17. Takahashi, T., M. Tanaka, C.I. Brannan, N.A. Jenkins, N.G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 76:969-976.
18. Kägi, D., B. Ledermann, K. Bürki, P. Seiler, B. Odermatt, K.J. Olsen, E.R. Podack, R.M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature (Lond.). 369:31-37.
19. Davidson, W.F., J.B. Roths, K.L. Holmes, E. Rudikoff, and H.C. Morse III. 1984. Dissociation of severe lupus-like disease from polyclonal B cell activation and IL-2 deficiency in C3H-lpr/lpr mice. J. Immunol. 133:1048-1056.
20. Cohen, P.L., and R.A. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243-269.
21. Scheid, M.P., K.S. Landreth, J. Tung, and P.W. Kincade. 1982. Preferential but nonexclusive expression of macromolecular antigens on B-lineage cells. Immunological Rev. 69: 141-159.
22. Suzuki, M., Y. Suzuki, H. Ikeda, M. Koike, M. Nomura, J. Tamura, S. Sato, Y. Hotta, and G. Itoh. 1994. Apoptosis of murine large intestine in acute graft-versus-host disease after allogeneic bone marrow transplantation across minor histocompatibility barriers. Transplantation. 57:1284-1287.
23. Kumpel, G.R., C.R. Annable, M.G. Cleveland, T.R. Jerrells, and J.C. Patterson. 1990. Immunosuppression and lymphoid hypoplasia associated with chronic graft versus host disease is dependent upon IFN-γ production. J. Immunol. 144: 84-93.
24. Beschorner, W.E., J. Pino, J.K. Boitnott, P.J. Tutschka, and G. W. Santos. 1980. Pathology of the liver with bone marrow transplantation. Am. J. Pathol. 99:369-386.
25. Gallucci, B.B., H.M. Shulman, G.E. Sale, K.G. Lerner, L.E. Caldwell, and E.D. Thomas. 1979. The ultrastructure of the human epidermis in chronic graft-versus-host disease. Am. J. Pathol. 95:643-662.
26. Gallucci, B.B., G.E. Sale, G.B. McDonald, R. Epstein, H.M. Shulman, and E.D. Thomas. 1982. The fine structure of human rectal epithelium in acute graft-versus-host disease. Am. J. Surg. Pathol. 6:293-305.
27. Suda, T., T. Okazaki, Y. Naito, T. Yokota, N. Arai, S. Ozaki, K. Nakao, and S. Nagata. 1995. Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154:3806-3813.
28. Ogasawara, J., R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. 1993. Lethal effect of the anti-Fas antibody in mice. Nature (Lond.). 364:806-809.
29. Sayama, K., S. Yonehara, Y. Watanabe, and Y. Miki. 1994. Expression of Fas antigen on Keratinocytes in vivo and induction of apoptosis in cultured keratinocytes. J. Invest. Dermatol. 103:330-334.
30. Tracey, K.J., H. Wei, K.R. Manogue, Y. Fong, D.G. Hesse, H.T. Nguyen, G.C. Kuo, B. Beutler, R.S. Cotran, A. Cerami, and S.F. Lowry. 1988. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J. Exp. Med. 167:1211-1227.
31. Holler, E., H.J. Kolb, A. Möller, J. Kempeni, S. Liesenfeld, H. Pechumer, W. Lemacher, G. Ruckdeschel, B. Gleixner, C. Riedner et al. 1990. Increased serum levels of tumor necrosis factor α precede major complications of bone marrow transplantation. Blood. 75:1011-1016.
32. Piguet, P.F., G.E. Grau, B. Allet, and P. Vassalli. 1987. Tumor necrosis factor/cachectin is an effector of skin and gut lesions in of the acute phase of graft-vs-host disease. J. Exp. Med. 166:1280-1289.
33. Murphy, G.F., D. Whitaker, J. Sprent, and R. Korngold. 1991. Characterization of target injury of murine acute graft-versus-host disease directed to multiple minor histocompatibility antigens elicited by either CD4+ or CD8+ effector cells. Am J. Pathol. 138:983-990.
34. Stalder, T., S. Hahn, and P. Erb. 1994. Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J. Immunol. 152:1127-1133.
35. Miyshima, S., N. Nagata, T. Nakagawa, N. Hosaka, K. Takeuchi, R. Ogawa, and S. Ikehara. 1996. Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice. J. Immunol. 156:79-84.
36. Allen, R.D., J.D. Marshall, J.B. Roths, and C.L. Sidman. 1990. Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules. J. Exp. Med. 172:1367-1375.
37. Selvaggi, G., L. Inverardi, R.B. Levy, M.D. Brendel, J. Spielman, D.H. Mintz, E.R. Podack, and C. Ricordi. 1995. Abrogation of graft-versus-host disease following allotransplantation of cytotoxically defcient bone marrow across major histocompatibility barriers. Ann. NY Acad. Sci. USA. 770: 339-344.
38. Jadus, M.R., and H.T. Wepsic. 1992.The role of cytokines in graft-versus-host reactions and disease. Bone Marrow Transplant. 10:1-14.